Biosecurity management with genetically modified organisms

On July 11, Prime Minister Nguyen Tan Dung signed the approval decision: The master plan to strengthen biosafety management capacity for genetically modified organisms and products and goods derived from organisms Genetically modified from now until 2010, implementing the Cartagena Protocol on Biosafety.

Decision 102/2007 / QD-TTg stated that biosecurity management is an inseparable task in the process of modern biotechnology research and development. Biosecurity management contributes to the development of modern biotechnology, gains many new achievements, and must include control measures, strict management and prevention of potential risks. In the above process, the aim is to protect the safety of human health, habitat and biodiversity, to serve the goal of sustainable development of the country.

The objective of the project is to build, promulgate and perfect the system of legal documents, mechanisms and policies on biosafety management; to train enough professional and professional personnel to meet the requirements of biosafety management in ministries, branches, localities and establishments; Raising awareness of the community on biosafety for genetically modified organisms and products and goods derived from genetically modified organisms. In addition, it is necessary to build and strengthen the material and technical bases in the direction of advanced and modern, ensuring enough laboratories in three regions of the country.

According to the Scheme of modern laboratory systems, it will be built to be capable of analyzing, identifying and accurately identifying genetically modified organisms, products derived from genetically modified organisms, and evaluated. , manage and control risks caused by the above objects.

The project also mentioned the diversification and effective use of investment capital for biosafety management as an important solution to realize the objectives and tasks of the project. Accordingly, gradually increase the level of investment from the state budget for biosafety management; prioritize investment in training human resources and enhance material and technical foundations, machinery and equipment in service of analysis, identification, identification, risk assessment, risk management and supervision for genetically modified organisms, products and goods derived from genetically modified organisms.

In addition to capital from the state budget, it is necessary to encourage, attract and exploit other sources of investment capital through bilateral and multilateral cooperation programs and projects; actively mobilize additional capital from domestic and foreign enterprises, organizations and individuals for this work.